Cargando…
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis (SSc) is an autoimmune connective tissue disease, characterized by immune dysregulation and progressive fibrosis. Interstitial lung disease (ILD) is the most common cause of death among SSc patients and there are currently very limited approved disease-modifying treatment options...
Autores principales: | Khedoe, Padmini, Marges, Emiel, Hiemstra, Pieter, Ninaber, Maarten, Geelhoed, Miranda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500178/ https://www.ncbi.nlm.nih.gov/pubmed/33013852 http://dx.doi.org/10.3389/fimmu.2020.01990 |
Ejemplares similares
-
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019) -
Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
por: Fields, Aislin, et al.
Publicado: (2023) -
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
por: Kreuter, Michael, et al.
Publicado: (2022) -
ChILD – Children's interstitial lung disease
Publicado: (2018) -
Interstitial lung disease pathology in systemic
sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)